Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Cancer Type/Condition:
Malignant fibrous histiocytoma of bone, child
Stage/Subtype:
metastatic childhood malignant fibrous histiocytoma of bone
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30 at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-ARST0332
, ARST0332, NCT00346164
2.
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
30 and under
Sponsor:
NCI, Other
Protocol IDs:
OS2008
, NCT00667342
3.
Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Eval. of the Efficacy of Ridaforolimus)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
13 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AP23573-07-302
, NCT00538239
4.
Trial of Dasatinib in Advanced Sarcomas
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 13
Sponsor:
Other
Protocol IDs:
SARC009
, NCT00464620
5.
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
IOSI-RO0402
, RO0402, NCT00637637
6.
Study of MK8669 With Metastatic Bone or Soft-tissue Sarcoma Patients
Phase:
Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
13 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
2009_688
, MK8669-030, NCT01010672
7.
Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
2 to 21
Sponsor:
NCI
Protocol IDs:
NCI-08-C-0007
, 08-C-0007, NCI-P6068, 7458, NCT00556881
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
